phenylephrine has been researched along with Heart Failure in 145 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (16.55) | 18.7374 |
1990's | 39 (26.90) | 18.2507 |
2000's | 29 (20.00) | 29.6817 |
2010's | 39 (26.90) | 24.3611 |
2020's | 14 (9.66) | 2.80 |
Authors | Studies |
---|---|
Cao, M; Dong, DL; Fu, Y; Gao, JL; Hu, N; Jiang, M; Li, WF; Ma, MH; Sun, ZJ; Yang, XR; Zhao, J | 1 |
Nowak, K; Okupnik, T; Olesińska-Mader, M; Paleczny, B; Podsiadły, A; Ponikowska, B; Ponikowski, P; Wyciszkiewicz, M; Łopusiewicz, W | 1 |
Bajpai, G; Bredemeyer, A; Feng, G; Förster, I; Koenig, A; Kreisel, D; Lai, L; Lavine, KJ; Leuschner, F; Lokshina, I; Ma, P | 1 |
Arbous, MS; Beeres, SLMA; Berendsen, RR; Bruggemans, EF; Hugo, JDV; Ince, C; Klautz, RJM; Lindeman, JHN; Mertens, BJA; Palmen, M; Papazisi, O; van den Hout, WB | 1 |
Funamoto, M; Hamabe-Horiike, T; Hasegawa, K; Katanasaka, Y; Kawaguchi, S; Kawase, Y; Komiyama, M; Miyazaki, Y; Mori, K; Morimoto, T; Murakami, A; Shimizu, K; Shimizu, S; Sunagawa, Y | 1 |
Antônio, EL; Arruda-Junior, DF; Dos Santos, DS; Fontes, MT; Girardi, ACC; Ribeiro-Silva, JC; Rossoni, LV; Tucci, PFJ | 1 |
Kokkonen-Simon, K; Kovacs, A; Li, T; Matkovich, SJ; Matsiukevich, D; Oladipupo, SS; Ornitz, DM | 1 |
Chen, Y; Cui, J; Cui, Y; Li, M; Tang, X; Wang, P; Wang, Y; Zhang, T | 1 |
Jiang, X; Jiang, Z; Sun, Y; Xu, C | 1 |
Chen, Y; Deng, KQ; Li, HP; Li, J; Tu, J; Wan, F; Wang, CQ; Xiao, WC | 1 |
Bystrova, OV; Grinevich, VB; Osipov, GA; Salikova, SP; Shperling, MI; Terkin, DA; Vlasov, AA | 1 |
Byun, J; Cawley, KM; Drakos, SG; Horiuchi, AK; Kumar, A; Ling, J; Mukai, R; O'Very, SA; Oka, SI; Sabry, AD; Sadoshima, J; Saijoh, Y; Shankar, TS; Taleb, I; Torres, NS; Warren, JS; Xu, X; Yazawa, M; Zaitsev, MA | 1 |
Chen, C; Dai, B; Fan, J; Li, H; Nie, X; Shi, X; Wang, DW; Wen, Z; Xie, R; Yin, Z; Yuan, S; Zhan, J; Zhang, X; Zhao, Y | 1 |
Funamoto, M; Hasegawa, K; Katanasaka, Y; Katayama, A; Miyazaki, Y; Morimoto, T; Nurmila, S; Shimizu, K; Shimizu, S; Sunagawa, Y | 1 |
Burris, TP; Chan, RE; Fu, C; Griffin, AC; Jain, MK; Liao, X; Shen, Y; Sugi, K; Tien, CL; Zhang, L; Zhang, R | 1 |
Danilowicz-Szymanowicz, L; La Rovere, MT; Maestri, R; Pinna, GD; Raczak, G | 1 |
Alloatti, G; Brancaccio, M; Carullo, P; Condorelli, G; Di Pasquale, E; Gallo, MP; Gesmundo, I; Ghigo, E; Granata, R; Hare, JM; Larcher, V; Mazzola, M; Miragoli, M; Penna, C; Schally, AV; Sorge, M; Taliano, M; Trovato, L; Villanova, T | 1 |
Deng, W; Duan, MX; Jiang, XH; Liao, HH; Tang, QZ; Wu, QQ; Xiao, Y; Yang, Z; Yuan, Y | 1 |
Cai, YY; Chen, HY; He, JH; Jiang, W; Lan, J; Li, H; Li, RL; Li, X; Tang, CS; Wang, W; Wang, XX; Wu, SS; Wu, Y; Xin, JJ; Xue, KY; Zhang, HY; Zhuo, CL | 1 |
Anker, SD; Banasiak, W; Buldańczyk, A; Jankowska, EA; Niewiński, P; Nowak, K; Olesińska-Mader, M; Paleczny, B; Ponikowska, B; Ponikowski, P; Siennicka, A; von Haehling, S | 1 |
Chaanine, AH | 1 |
Cai, ZL; Deng, W; Duan, MX; Liu, C; Tang, QZ; Wu, QQ; Xie, QW; Xie, SY; Yuan, Y | 1 |
Blanc, J; Catalucci, D; De Windt, LJ; Diguet, N; Escoubet, B; Lefebvre, F; Li, Z; Mallat, Y; Mericskay, M; Tritsch, E; Vandecasteele, G | 1 |
Jiang, Y; Li, Y; Qin, Y; Wang, Q; Xia, Q | 1 |
Banach, K; Burmeister, BT; Carnegie, GK; Conklin, BR; DeSantiago, J; Johnson, KR; Monasky, MM; Spindler, MJ; Taglieri, DM | 1 |
Hasan, W; Smith, PG | 1 |
Liskova, IuV; Salikova, SP; Stadnikov, AA | 1 |
Fernandes, AA; Padilha, AS; Silveira, EA; Siman, FD; Stefanon, I; Vassallo, DV | 1 |
Iwai-Kanai, E; Katamura, M; Matoba, S; Mita, Y; Nakaoka, M; Okawa, Y | 1 |
Ding, W; Dong, M; Liao, Y; Liu, J; Liu, S; Liu, Y; Wang, R; Yan, D; Zhang, Y; Zheng, N | 1 |
Asakura, M; Bin, J; Cao, S; Huang, X; Kitakaze, M; Liao, Y; Wei, X; Wu, B; Xu, D; Xuan, W; Zeng, Z; Zhao, J | 1 |
Abdellatif, M; Falcão-Pires, I; Fontoura, D; Leite, S; Leite-Moreira, AF; Lourenço, AP; Oliveira-Pinto, J; Tavares-Silva, M | 1 |
Boheler, KR; Huang, Y; Kong, CW; Li, RA; Li, ZC; Poon, E; Wang, Y; Yao, X; Zhang, P | 1 |
Bernstein, SI; Cammarato, A; Harding, SE; Kass, DA; Kooij, V; Kronert, WA; Lee, DI; Rainer, PP; Schmidt, W; Van Eyk, JE; Viswanathan, MC | 1 |
Ebuchi, K; Hattori, K; Kamei, M; Maeda, T; Masubuchi, T; Morishima, K; Ohnishi, Y; Yoshikawa, A; Yoshitani, K | 1 |
Chaanine, AH; Fayyaz, AU; Gamb, SI; Guenzel, AJ; Hajjar, RJ; Klaus, K; Kohlbrenner, E; Nair, KS; Redfield, MM | 1 |
Burton, JP; Ettinger, G; Gloor, GB; Reid, G | 1 |
Aaronson, KD; Koelling, TM; Matthews, JC; Pagani, FD | 1 |
Gilbert, EM; Huggins, F; Munger, MA; Rondina, MT; Van Tassell, BW | 1 |
Hikoso, S; Hori, M; Mano, T; Masuyama, T; Miwa, T; Nishio, M; Ohtani, T; Otsu, K; Sakata, Y; Takeda, Y; Yamamoto, K | 1 |
Hill, JA; Keller, RS; Yund, EE | 1 |
Armesilla, AL; Baudoin-Stanley, F; Cartwright, EJ; Mohamed, TM; Nadif, R; Neyses, L; Oceandy, D; Pfeifer, GP; Pickard, A; Prehar, S; Stanley, PJ; Tommasi, S; Zi, M | 1 |
Ho, JK; Liakopoulos, OJ; Mahajan, A; Sanchez, E; Singh, V; Yezbick, AB | 1 |
Cha, H; Choi, BY; Hajjar, RJ; Jang, SP; Jeong, D; Jeong, MH; Kim, J; Lee, MA; Park, WJ; Yang, DK; Yoon, PO | 1 |
Cokkinos, DV; Galanopoulos, G; Gavra, M; Mourouzis, I; Pantos, C; Perimenis, P; Spanou, D | 1 |
Antonio, EL; dos Santos, L; Souza, AF; Tucci, PJ | 1 |
Harris, GS; Katwa, LC; Lust, RM; Wingard, CJ | 1 |
Faruq, NS; Gan, XT; Guo, J; Haist, JV; Karmazyn, M; Rajapurohitam, V; Zeidan, A | 1 |
Febo, O; La Rovere, MT; Maestri, R; Pinna, GD; Sleight, P | 1 |
Caporotondi, A; Febo, O; Guazzotti, G; La Rovere, MT; Maestri, R; Pinna, GD; Robbi, E | 1 |
dos Remedios, C; Kaye, DM; Khammy, O; Maeder, MT | 1 |
Agarwal, S; Babbar, R; Fahim, M; Kotwani, A; Parveen, A | 1 |
Chu, M; Heroux, AL; Iyengar, R; Kim, T; Koshman, YE; Martin, JL; Robia, SL; Russell, B; Samarel, AM | 1 |
de Boer, RA; Lu, B; Ruifrok, WP; Silljé, HH; Tigchelaar, W; van Gilst, WH | 1 |
Coves, S; Holgado, CM | 1 |
Basu, R; Das, SK; Kassiri, Z; Lopaschuk, GD; McLean, BA; Mori, J; Oudit, GY; Patel, VB; Wagg, CS; Zhang, L | 1 |
Curry, PL; Gao, L; Haack, KK; Pellegrino, PR; Schiller, AM; Zucker, IH | 1 |
Buchneva, NV; Kuz'min, OB | 1 |
Benetti, M; Bolla, GB; Fedele, L; Ferrari, AU; Mircoli, L; Perlini, S; Radaelli, A | 1 |
Bøkenes, J; Osnes, JB; Qvigstad, E; Sandnes, D; Schiander, I; Sejersted, OM; Sjaastad, I; Sjetnan, A; Skomedal, T | 1 |
Hasegawa, K; Hirai, M; Kawamura, T; Kawase, Y; Kita, T; Matsumori, A; Morimoto, T; Wada, H; Yanazume, T | 1 |
GREENOUGH, WB; JANUSZEWICZ, V; LARAGH, JH; SONNENBLICK, EH | 1 |
AGRESS, CM | 1 |
GADBOYS, HL; LITWAK, RS; WISOFF, G | 1 |
ROBINSON, HJ; WAGNER, JA | 1 |
Esposito, DJ; Glower, DD; Owen, CH; Thompson, RB; van den Bos, EJ | 1 |
Asakura, M; Asano, Y; Asanuma, H; Hori, M; Kim, J; Kitakaze, M; Kitamura, S; Liao, Y; Minamino, T; Ogai, A; Sanada, S; Shintani, Y; Takashima, S; Tomoike, H | 1 |
Dell'Oro, R; Facchini, A; Grassi, G; Ilardo, V; Mancia, G; Seravalle, G | 1 |
Frenneaux, MP | 1 |
Pereira, RB; Sartório, CL; Stefanon, I; Vassallo, DV | 1 |
Abbott, JA; Broadstone, RV; Pyle, RL; Ward, DL | 1 |
Bøkenes, J; Osnes, JB; Qvigstad, E; Schiander, I; Sejersted, OM; Sjaastad, I; Skomedal, T; Solberg, L | 1 |
Glower, DD; Hata, JA; Mathew, JP; Milano, CA; Muhlbaier, LH; O'Connor, CM; Schroder, JN; Smith, PK; Swaminathan, M; Williams, ML | 1 |
Force, T; Goruppi, S; Kyriakis, JM; Patten, RD | 1 |
Bertozzi, C; Chen, M; Cheng, L; Graf, T; Kahn, ML; Lee, JS; Lepore, JJ; Lo, CW; MacRae, CA; Mericko, P; Sebzda, E; Shin, JT; Stadtfeld, M; Yu, Q; Zhou, D | 1 |
Cornish, KG; Liu, D; Mousa, TM; Zucker, IH | 1 |
Grüber, M; Hasenfuss, G; Jacobshagen, C; Kögler, H; Maier, LS; Nguyen, VP; Schmidt, AG; Teucher, N; Toischer, K; Unsöld, BW | 1 |
Arimoto, T; Bilim, O; Goto, K; Ishino, M; Kitahara, T; Kubota, I; Nakajima, O; Niizeki, T; Sasaki, T; Suzuki, S; Takeishi, Y; Walsh, RA | 1 |
Engler, R; Slutsky, RA; Watkins, J | 1 |
Hirshfeld, JW; Laskey, WK; Reichek, N; Sutton, MS; Zeevi, G | 1 |
White, CW | 1 |
Gomes, GI; Gould, L; Patel, S; Reddy, CV | 1 |
Forster, C | 2 |
Delehanty, JM; Himura, Y; Hood, WB; Liang, CS | 1 |
Merin, RG | 1 |
Bolla, GB; Cattaneo, BM; Del Bo, A; Giannattasio, C; Grassi, G; Lanfranchi, A; Pozzi, M; Sala, C; Seravalle, G; Vailati, S | 1 |
Failla, M; Fraschini, N; Giannattasio, C; Grassi, G; Mancia, G; Marinoni, E; Peretti, G; Pesenti, A; Vailati, S | 1 |
Armstrong, PW; Forster, C; Larosa, G | 1 |
Ceravolo, R; Chiariello, M; Condorelli, M; Esposito, G; Indolfi, C; Maione, A; Rapacciuolo, A; Rendina, V; Volpe, M | 1 |
Hintze, TH; Seyedi, N; Wang, J; Wolin, MS; Xu, XB | 1 |
Gabel, M; Hoit, BD; Shao, Y; Walsh, RA | 1 |
Armstrong, PW; Grima, EA; Howard, RJ; Moe, GW | 1 |
Creager, MA; Creager, SJ | 1 |
Buikema, H; de Smet, BJ; Lie, KI; Scholtens, E; van Gilst, WH; van Veldhuisen, DJ; Wesseling, H | 1 |
Andries, JL; Brutsaert, DL; Calderone, A; Li, K; Rouleau, JL | 1 |
McGrath, BP; Miura, Y; Noshiro, T; Way, D | 1 |
Li, K; Rouleau, JL | 1 |
Fayngersh, R; Gewitz, MH; Hintze, TH; Mathew, R; Omar, HA; Shen, W; Wang, J; Wolin, MS | 1 |
Aass, H; Borthne, K; Geiran, O; Osnes, JB; Skomedal, T | 1 |
Comoy, E; Compagnon, P; Devaux, B; Elfertak, L; Henry, JP; Macé, B; Mulder, P; Richard, V; Thibout, E; Thuillez, C; Wimart, MC | 1 |
Ahmed, MW; Goldberger, JJ; Inbar, S; Kadish, AH | 1 |
Goldsmith, SR | 1 |
McGrath, BP; Noshiro, T; Way, D | 1 |
Forster, C; Le Tran, Y | 1 |
Cooper, CJ; Dickinson, J; Jevnikar, FW; Mouhaffel, A; Selwyn, AP; Walsh, T | 1 |
Huang, BS; Leenen, FH; Zhang, W | 1 |
Gaballa, MA; Goldman, S | 1 |
Bauersachs, J; Bouloumié, A; Busse, R; Ertl, G; Fraccarollo, D; Hu, K | 1 |
Edvinsson, L; Feng, Q; Hedner, T; Lu, X; Sun, X | 1 |
Coats, AJ; Colombo, R; Giannuzzi, P; Lanfranchi, P; Mazzuero, G; Minuco, G; Ponikowski, P; Spinatonda, G | 1 |
Coats, AJ; Davies, LC; Francis, D; Jurák, P; Kára, T; Piepoli, M | 1 |
Fukuma, N; Fukuma, Y; Hayakawa, H; Kishida, H; Munakata, K; Takano, T | 1 |
Davey, P | 1 |
Lim, PO; Ogston, SA; Struthers, AD; Yee, KM | 1 |
Bertinieri, G; Grassi, G; Mancia, G; Scopelliti, F; Seravalle, G; Stella, ML; Turri, C | 1 |
Bertinieri, G; Grassi, G; Mancia, G; Pierini, A; Seravalle, G; Turri, C | 1 |
Belló Klein, A; Bock, P; Cervo, F; Cláudia Irigoyen, M; Clausell, N; De Angelis, K; Gatelli Fernandes, T; Rabelo, E | 1 |
Bennett, SR; Drew, P; Griffin, S; McKeown, J | 1 |
Chowdhary, S; Coote, JH; Ng, GA; Nuttall, SL; Ross, HF; Townend, JN | 1 |
La Rovere, MT; Maestri, R; Pinna, GD; Raczak, G | 1 |
Bhatnagar, RK; Lund, DD; McNamara, RF; Schmid, PG; Schmidt, JA | 1 |
Cairns, JA | 1 |
Cohn, JN; Levine, TB; Mashiro, I; Mehta, J | 1 |
Redwood, DR | 1 |
Conti, CR; Curry, RC; Nichols, WW; Pepine, CJ | 1 |
Hoffman, JI; Turley, K; Vlahakes, GJ | 1 |
Bianchi, C; Borer, JS; Cagin, N; Epstein, SE; Levitt, B; Redwood, DR; Vallin, H | 1 |
Asanoi, H; Ishizaka, S; Kameyama, T; Sasayama, S | 1 |
Colucci, WS; Gauthier, DF; Landzberg, JS; Parker, JD | 1 |
Inukai, T; Katahira, J; Nakao, K; Tanaka, M | 1 |
Berg, WJ; Ferguson, DW; Mark, AL; Oren, RM; Roach, PJ | 1 |
Wang, W; Zucker, IH | 1 |
Gallo Júnior, L; Maciel, BC; Marin-Neto, JA; Pintya, AO | 1 |
Ferraro, N; Frey, MJ; Lanoce, V; Wilson, JR | 1 |
Colucci, WS; Creager, MA; Cutler, SS; Dzau, VJ; Hirsch, AT; Nabel, EG | 1 |
Böhm, M; Diet, F; Erdmann, E; Feiler, G; Kemkes, B | 1 |
Armstrong, PW; Carter, SL; Forster, C | 1 |
Liang, CS; Sakamoto, S | 1 |
Armstrong, P; Carter, S; Forster, C | 1 |
Ellenbogen, KA; Mohanty, PK; Szentpetery, S; Thames, MD | 1 |
Ivanova, TN; Pavlova, LT | 1 |
Braunwald, E; Eckberg, DL; Higgins, CB; Vatner, SF | 1 |
Chervinskiĭ, AA; Gol'dberg, GA; Grishchenko, VN; Tatarchenko, IP | 1 |
Cloup, M; Fidelle, J; Nouaille, J | 1 |
4 review(s) available for phenylephrine and Heart Failure
Article | Year |
---|---|
THERAPY OF CARDIOGENIC SHOCK.
Topics: Angiotensins; Cardiac Tamponade; Heart Aneurysm; Heart Diseases; Heart Failure; Humans; Hydromorphone; Meperidine; Mephentermine; Metaraminol; Methoxamine; Morphine; Myocarditis; Norepinephrine; Oxygen; Pericarditis; Phentolamine; Phenylephrine; Pulmonary Heart Disease; Shock; Shock, Cardiogenic | 1963 |
Autonomic changes in patients with heart failure and in post-myocardial infarction patients.
Topics: Arrhythmias, Cardiac; Baroreflex; Cardiotonic Agents; Heart Failure; Heart Rate; Humans; Myocardial Infarction; Phenylephrine; Prognosis | 2004 |
Myocardial infarction size: measurement and modification.
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Coronary Disease; Creatine Kinase; Digitalis Glycosides; Electrocardiography; Heart Failure; Humans; Myocardial Infarction; Myocardium; Nitroglycerin; Ontario; Oxidoreductases; Oxygen Consumption; Phenylephrine; Practolol; Propranolol; Radionuclide Imaging; Shock, Cardiogenic; Staining and Labeling; Technetium | 1977 |
Role of vasoconstrictor mechanisms in the control of left ventricular performance of the normal and damaged heart.
Topics: Animals; Captopril; Cardiography, Impedance; Dogs; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Hypertension; Phenylephrine; Plethysmography, Impedance; Renin; Stroke Volume; Teprotide; Vasoconstriction | 1979 |
9 trial(s) available for phenylephrine and Heart Failure
Article | Year |
---|---|
Valsalva-derived Measures and Phenylephrine Test in Patients With Heart Failure With Reduced Ejection Fraction Receiving Comprehensive Neurohormonal Blockade Drug Therapy: A 5-year Event-free Survival Analysis.
Topics: Heart Failure; Humans; Phenylephrine; Progression-Free Survival; Retrospective Studies; Stroke Volume; Ventricular Dysfunction, Left | 2022 |
Prevention of vasoplegia with CytoSorb in heart failure patients undergoing cardiac surgery (CytoSorb-HF trial): protocol for a randomised controlled trial.
Topics: Cardiac Surgical Procedures; Heart Failure; Humans; Inflammation Mediators; Phenylephrine; Randomized Controlled Trials as Topic; Systemic Inflammatory Response Syndrome; Vasoplegia | 2022 |
Sympathetic and baroreflex function in hypertensive or heart failure patients with ventricular arrhythmias.
Topics: Adult; Antihypertensive Agents; Baroreflex; Blood Pressure; Echocardiography; Electrocardiography; Heart Failure; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nitroprusside; Phenylephrine; Sympathetic Nervous System; Sympathomimetics; Ventricular Premature Complexes | 2004 |
Effect of amlodipine on norepinephrine kinetics and baroreflex function in patients with congestive heart failure.
Topics: Aged; Amlodipine; Baroreflex; Blood Pressure; Calcium Channel Blockers; Cardiotonic Agents; Chronic Disease; Efferent Pathways; Forearm; Head-Down Tilt; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Neurotransmitter Agents; Norepinephrine; Phenylephrine; Placebos; Radiopharmaceuticals; Regional Blood Flow; Respiratory Insufficiency; Sympathomimetics; Tilt-Table Test; Tritium; Vascular Resistance; Ventricular Dysfunction, Left | 1997 |
Comparison between spectral analysis and the phenylephrine method for the assessment of baroreflex sensitivity in chronic heart failure.
Topics: Adult; Aged; Baroreflex; Heart Failure; Humans; Middle Aged; Models, Cardiovascular; Phenylephrine; Regression Analysis; Reproducibility of Results; Respiration; Signal Processing, Computer-Assisted; Vasoconstrictor Agents | 1999 |
Reproducibility of methods for assessing baroreflex sensitivity in normal controls and in patients with chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Baroreflex; Female; Heart Failure; Humans; Male; Middle Aged; Phenylephrine; Reproducibility of Results; Respiration; Signal Processing, Computer-Assisted; Vasoconstrictor Agents | 1999 |
Effect of phenylephrine with and without atropine on QT dispersion in healthy normotensive men.
Topics: Adrenergic alpha-Agonists; Adult; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atropine; Blood Pressure; Cardiotonic Agents; Cross-Over Studies; Death, Sudden, Cardiac; Drug Monitoring; Drug Therapy, Combination; Electrocardiography; Heart Failure; Heart Rate; Humans; Hypertension; Infusions, Intravenous; Male; Phenylephrine; Sensitivity and Specificity; Single-Blind Method; Vagus Nerve | 2000 |
Effects of chronic clonidine administration on sympathetic nerve traffic and baroreflex function in heart failure.
Topics: Baroreflex; Blood Pressure; Clonidine; Double-Blind Method; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Nitroprusside; Norepinephrine; Phenylephrine; Sympathetic Nervous System; Sympatholytics | 2001 |
Angiotensin in cardiac surgery: efficacy in patients on angiotensin converting enzyme inhibitors.
Topics: Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiac Surgical Procedures; Female; Heart Failure; Humans; Hypertension; Male; Middle Aged; Phenylephrine; Vascular Resistance; Vasoconstrictor Agents | 2001 |
132 other study(ies) available for phenylephrine and Heart Failure
Article | Year |
---|---|
Anthelmintic niclosamide attenuates pressure-overload induced heart failure in mice.
Topics: Adenosine Triphosphate; Animals; Anthelmintics; Cardiomegaly; Cell Line; Collagen; Disease Models, Animal; Enalapril; Fibroblasts; Heart Failure; Humans; Interleukin-6; Macrophages; Male; Mice; Mitochondria; Myocytes, Cardiac; Niclosamide; Phenylephrine; Proto-Oncogene Proteins c-bcl-2; Rats; STAT3 Transcription Factor; Survivin | 2021 |
CCL17 Aggravates Myocardial Injury by Suppressing Recruitment of Regulatory T Cells.
Topics: Angiotensin II; Animals; Chemokine CCL17; Diphtheria Toxin; Heart Failure; Humans; Inflammation; Ligands; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Infarction; Phenylephrine; T-Lymphocytes, Regulatory; Ventricular Remodeling | 2022 |
Auraptene, a citrus peel-derived natural product, prevents myocardial infarction-induced heart failure by activating PPARα in rats.
Topics: Animals; Atrial Natriuretic Factor; Biological Products; Cardiomegaly; Citrus; Coumarins; Endothelin-1; Fibrosis; Heart Failure; Myocardial Infarction; Peroxisome Proliferators; Phenylephrine; PPAR alpha; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2022 |
Dipeptidyl peptidase 4 inhibition rescues PKA-eNOS signaling and suppresses aortic hypercontractility in male rats with heart failure.
Topics: Animals; Aorta; Cyclic AMP-Dependent Protein Kinases; Dipeptidyl Peptidase 4; Endothelium, Vascular; Heart Failure; Male; Nitric Oxide Synthase Type III; Phenylephrine; Rats; Rats, Wistar; Vildagliptin | 2023 |
Characterization of a robust mouse model of heart failure with preserved ejection fraction.
Topics: Angiotensin II; Animals; Cardiomyopathies; Disease Models, Animal; Fibrosis; Heart Failure; Mice; Phenylephrine; Stroke Volume; Ventricular Function, Left | 2023 |
Cinnamic acid mitigates left ventricular hypertrophy and heart failure in part through modulating FTO-dependent N
Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Disease Models, Animal; Heart Failure; Hypertrophy, Left Ventricular; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Phenylephrine; RNA | 2023 |
DEF6(differentially exprehomolog) exacerbates pathological cardiac hypertrophy via RAC1.
Topics: Animals; Cardiomegaly; Disease Models, Animal; Heart Failure; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; Phenylephrine; Signal Transduction | 2023 |
TRAF Family Member 4 Promotes Cardiac Hypertrophy Through the Activation of the AKT Pathway.
Topics: Animals; Cardiomegaly; Heart Failure; Mice; Phenylephrine; Proto-Oncogene Proteins c-akt; Rats; TNF Receptor-Associated Factor 4 | 2023 |
Effect of Prebiotic Complex on Gut Microbiota and Endotoxemia in Female Rats with Modeled Heart Failure.
Topics: Animals; Animals, Outbred Strains; Bacteria; Bifidobacterium; Disease Models, Animal; Dysbiosis; Endotoxemia; Endotoxins; Female; Gastrointestinal Microbiome; Heart Failure; Phenylephrine; Physical Exertion; Prebiotics; Propionibacterium; Rats | 2020 |
Perm1 regulates cardiac energetics as a downstream target of the histone methyltransferase Smyd1.
Topics: Adult; Aged; Animals; Disease Models, Animal; DNA Methylation; DNA-Binding Proteins; Down-Regulation; Electron Transport Complex I; Energy Metabolism; ERRalpha Estrogen-Related Receptor; Female; Gene Expression Regulation; Gene Knockdown Techniques; Heart Failure; Heart Transplantation; Histones; Humans; Intracellular Signaling Peptides and Proteins; Male; Mice; Middle Aged; Mitochondria; Muscle Proteins; Myocardium; Myocytes, Cardiac; Oxidative Phosphorylation; Phenylephrine; Primary Cell Culture; Promoter Regions, Genetic; Rats; Receptors, Estrogen; RNA-Seq; RNA, Small Interfering; Transcription Factors | 2020 |
LncRNA ZNF593-AS Alleviates Contractile Dysfunction in Dilated Cardiomyopathy.
Topics: Animals; Aorta; Calcium; Cardiomyopathy, Dilated; Cytoplasm; DNA-Binding Proteins; Heart Failure; Heterogeneous-Nuclear Ribonucleoprotein Group C; Humans; Mice; Myocardial Contraction; Myocytes, Cardiac; Phenylephrine; RNA, Long Noncoding; RNA, Messenger; Ryanodine Receptor Calcium Release Channel; Tissue Array Analysis; Transcription Factors; Vasoconstriction | 2021 |
Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes.
Topics: Acetylation; Adrenergic alpha-1 Receptor Agonists; Animals; Cardiomegaly; Cells, Cultured; E1A-Associated p300 Protein; Heart Failure; Histone Acetyltransferases; Metformin; Myocytes, Cardiac; Phenylephrine; Rats, Sprague-Dawley | 2021 |
REV-ERBα ameliorates heart failure through transcription repression.
Topics: Animals; Cardiotonic Agents; Gene Expression; Gene Regulatory Networks; Heart Failure; Humans; Hypertrophy; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Nuclear Receptor Subfamily 1, Group D, Member 1; Phenylephrine; Rats; Rats, Sprague-Dawley; Transcription, Genetic | 2017 |
Estimation of baroreflex sensitivity by the bivariate phase rectified signal averaging method: a comparison with the phenylephrine method.
Topics: Baroreflex; Female; Heart Failure; Heart Function Tests; Humans; Male; Middle Aged; Myocardial Infarction; Phenylephrine; Signal Processing, Computer-Assisted | 2017 |
Growth hormone-releasing hormone attenuates cardiac hypertrophy and improves heart function in pressure overload-induced heart failure.
Topics: Animals; Apoptosis; Calcineurin; Cardiomegaly; Cell Line; Cyclic AMP-Dependent Protein Kinases; Growth Hormone-Releasing Hormone; Heart; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Phenylephrine; Phospholipase C beta; Protein Kinase C; Rats; Signal Transduction | 2017 |
Aucubin protects against pressure overload-induced cardiac remodelling via the β
Topics: Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Animals; Cardiotonic Agents; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Heart Failure; Hypertrophy; Iridoid Glucosides; Male; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; Nitric Oxide Synthase Type I; Oxidative Stress; Phenylephrine; Protective Agents; Rats; Receptors, Adrenergic, beta-3; Ventricular Remodeling | 2018 |
Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Autophagy; Autophagy-Related Protein-1 Homolog; Benzamides; Cardiomegaly; Fibronectins; Heart Failure; Humans; Mice; Mice, Transgenic; Myocytes, Cardiac; Phenylephrine; Pressure; Pyrimidines; Signal Transduction; TOR Serine-Threonine Kinases | 2018 |
Assessment of baroreflex sensitivity has no prognostic value in contemporary, optimally managed patients with mild-to-moderate heart failure with reduced ejection fraction: a retrospective analysis of 5-year survival.
Topics: Baroreflex; Defibrillators, Implantable; Electrocardiography; Exercise Test; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Phenylephrine; Poland; Predictive Value of Tests; Prognosis; Prospective Studies; Stroke Volume; Survival Rate; Sympathomimetics; Time Factors; Ventricular Function, Left | 2019 |
Morphological Stages of Mitochondrial Vacuolar Degeneration in Phenylephrine-Stressed Cardiac Myocytes and in Animal Models and Human Heart Failure.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Heart Failure; Mitochondria, Heart; Myocytes, Cardiac; Oxidative Stress; Phenylephrine; Rats; Rats, Sprague-Dawley | 2019 |
Zingerone attenuates aortic banding-induced cardiac remodelling via activating the eNOS/Nrf2 pathway.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Aorta; Cardiomegaly; Cells, Cultured; Fibrosis; Guaiacol; Heart Failure; Inflammation; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Myocytes, Cardiac; NF-E2-Related Factor 2; Nitric Oxide Synthase Type III; Oxidative Stress; Phenylephrine; Rats; Signal Transduction; Ventricular Remodeling | 2019 |
An SRF/miR-1 axis regulates NCX1 and annexin A5 protein levels in the normal and failing heart.
Topics: Animals; Annexin A5; Caffeine; Calcium; Calcium Signaling; Cardiomyopathy, Dilated; Cell Line; Disease Models, Animal; Gene Expression Regulation; Genotype; Heart Failure; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; Mutation; Myocytes, Cardiac; Phenotype; Phenylephrine; Rats; Rats, Wistar; RNA, Messenger; Serum Response Factor; Sodium-Calcium Exchanger; Time Factors; Transfection | 2013 |
[Effect of aldosterone on mesenteric resistance vessels in normal or heart failure rats and its mechanism].
Topics: Aldosterone; Animals; Heart Failure; Male; Mesenteric Arteries; Phenylephrine; Rats; Rats, Sprague-Dawley; Vasoconstriction | 2013 |
The C-terminus of the long AKAP13 isoform (AKAP-Lbc) is critical for development of compensatory cardiac hypertrophy.
Topics: A Kinase Anchor Proteins; Angiotensin II; Animals; Aorta; Apoptosis; Cardiomegaly; Collagen; Female; Gene Expression Regulation; Guanine Nucleotide Exchange Factors; Heart Failure; Histone Deacetylases; Male; Mice; Mice, Transgenic; Minor Histocompatibility Antigens; Myocardium; Phenylephrine; Protein Kinase C; Protein Structure, Tertiary; Signal Transduction | 2014 |
Decreased adrenoceptor stimulation in heart failure rats reduces NGF expression by cardiac parasympathetic neurons.
Topics: Adrenergic alpha-Agonists; Adrenergic Antagonists; Adrenergic beta-Agonists; Animals; Cells, Cultured; Heart; Heart Failure; Isoproterenol; Male; Nerve Growth Factor; Nerve Growth Factors; Neurons; Parasympathetic Nervous System; Phenylephrine; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic; RNA, Messenger; Time Factors; Vasoactive Intestinal Peptide; Vesicular Acetylcholine Transport Proteins | 2014 |
[Structural reorganization of the myocardium in ovariectomized rats with experimental heart failure after melatonin administration].
Topics: Animals; Apoptosis; Female; Heart; Heart Failure; Heart Ventricles; Humans; Melatonin; Myocardium; Myocytes, Cardiac; Ovariectomy; Phenylephrine; Rats; Swimming | 2013 |
Ouabain induces nitric oxide release by a PI3K/Akt-dependent pathway in isolated aortic rings from rats with heart failure.
Topics: Animals; Aorta, Thoracic; Heart Failure; Male; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Ouabain; Phenylephrine; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar | 2015 |
An alpha-adrenergic agonist protects hearts by inducing Akt1-mediated autophagy.
Topics: Adrenergic alpha-Agonists; Animals; Animals, Newborn; Apoptosis; Autophagy; Cardiotonic Agents; Green Fluorescent Proteins; Heart; Heart Failure; Isoproterenol; Mice; Mice, Inbred C57BL; Mice, Transgenic; Norepinephrine; Phenylephrine; Proto-Oncogene Proteins c-akt; Rats; TOR Serine-Threonine Kinases | 2015 |
Polydatin prevents hypertrophy in phenylephrine induced neonatal mouse cardiomyocytes and pressure-overload mouse models.
Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Cardiotonic Agents; Cell Size; Cells, Cultured; Disease Models, Animal; Drugs, Chinese Herbal; Glucosides; Heart Failure; Heart Ventricles; Male; Mice, Inbred C57BL; Oxidative Stress; Phenylephrine; Rats; rho-Associated Kinases; Stilbenes; Ventricular Remodeling | 2015 |
Myocardial Hypertrophic Preconditioning Attenuates Cardiomyocyte Hypertrophy and Slows Progression to Heart Failure Through Upregulation of S100A8/A9.
Topics: Animals; Aortic Valve Stenosis; Calcineurin; Calgranulin A; Calgranulin B; Cardiomyopathy, Hypertrophic; Cells, Cultured; Disease Models, Animal; Disease Progression; Gene Expression Regulation; Genetic Vectors; Heart Failure; Hypertrophy; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; NFATC Transcription Factors; Phenylephrine; Rats; Recombinant Fusion Proteins; RNA, Messenger | 2015 |
Echocardiography and invasive hemodynamics during stress testing for diagnosis of heart failure with preserved ejection fraction: an experimental study.
Topics: Animals; Area Under Curve; Cardiac Catheterization; Disease Models, Animal; Dobutamine; Echocardiography, Doppler; Echocardiography, Stress; Exercise Tolerance; Feasibility Studies; Head-Down Tilt; Heart Failure; Hemodynamics; Male; Obesity; Oxygen Consumption; Phenylephrine; Predictive Value of Tests; Rats, Inbred WKY; Rats, Zucker; Reproducibility of Results; ROC Curve; Stroke Volume; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2015 |
Nitric Oxide-cGMP-PKG Pathway Acts on Orai1 to Inhibit the Hypertrophy of Human Embryonic Stem Cell-Derived Cardiomyocytes.
Topics: Calcium; Calcium Channels; Cardiomegaly; Cell Differentiation; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Gene Expression Regulation; Heart Failure; Human Embryonic Stem Cells; Humans; Myocytes, Cardiac; Nitric Oxide; ORAI1 Protein; Phenylephrine; Phosphorylation; Signal Transduction | 2015 |
Profilin modulates sarcomeric organization and mediates cardiomyocyte hypertrophy.
Topics: Animals; Cardiomegaly; Drosophila melanogaster; Endothelin-1; Heart Failure; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Myofibrils; Phenylephrine; Profilins; Sarcomeres | 2016 |
Accuracy and Trending Ability of the Fourth-Generation FloTrac/Vigileo System in Patients With Low Cardiac Index.
Topics: Adult; Aged; Aged, 80 and over; Anesthesia, General; Cardiac Output; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Echocardiography, Three-Dimensional; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Monitoring, Intraoperative; Observer Variation; Phenylephrine; Prospective Studies; Prosthesis Implantation; Reproducibility of Results; Thermodilution; Vasoconstrictor Agents; Young Adult | 2017 |
FOXO3a regulates BNIP3 and modulates mitochondrial calcium, dynamics, and function in cardiac stress.
Topics: Animals; Blotting, Western; Calcium; Calcium-Binding Proteins; Cell Survival; Citrate (si)-Synthase; Disease Models, Animal; Dynamins; Echocardiography; Electron Transport Complex IV; Endoplasmic Reticulum; Fluorescent Antibody Technique; Forkhead Box Protein O3; Heart Failure; In Vitro Techniques; Male; Membrane Potential, Mitochondrial; Membrane Proteins; Microscopy, Electron, Transmission; Mitochondria, Heart; Mitochondrial Proteins; Myocytes, Cardiac; Phenylephrine; Phosphorylation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Stress, Physiological; Stroke Volume; Sympathomimetics; Ventricular Function, Left; Ventricular Remodeling | 2016 |
Lactobacillus rhamnosus GR-1 Attenuates Induction of Hypertrophy in Cardiomyocytes but Not through Secreted Protein MSP-1 (p75).
Topics: Animals; Animals, Newborn; Atrial Natriuretic Factor; Bacterial Proteins; Cardiomegaly; Disease Models, Animal; Heart Failure; Lacticaseibacillus rhamnosus; Myocytes, Cardiac; Phenylephrine; Probiotics; Rats; Rats, Sprague-Dawley | 2017 |
The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates.
Topics: Databases as Topic; Female; Health Status Indicators; Heart Failure; Heart Ventricles; Heart-Assist Devices; Hemodynamics; Humans; Male; Middle Aged; Odds Ratio; Phenylephrine; Preoperative Care; Prospective Studies; Risk Assessment; Risk Factors; ROC Curve; Vasopressins | 2008 |
Carvedilol increases blood pressure response to phenylephrine infusion in heart failure subjects with systolic dysfunction: evidence of improved vascular alpha1-adrenoreceptor signal transduction.
Topics: Adrenergic alpha-Agonists; Adrenergic Antagonists; Adult; Aged; Aged, 80 and over; Blood Pressure; Carbazoles; Carvedilol; Female; Heart Failure; Humans; Male; Middle Aged; Phenylephrine; Propanolamines; Prospective Studies; Receptors, Adrenergic, alpha-1; Signal Transduction; Systole; Ventricular Dysfunction | 2008 |
Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Atrial Natriuretic Factor; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Corticosterone; Disease Progression; Gene Expression; Glucocorticoids; Heart Failure; Male; Mice; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Myosin Heavy Chains; Phenylephrine; Rats; Rats, Inbred Dahl; Steroids | 2009 |
Hic-5 is required for fetal gene expression and cytoskeletal organization of neonatal cardiac myocytes.
Topics: Actinin; Animals; Animals, Newborn; Cardiomegaly; Cytoskeletal Proteins; Cytoskeleton; Disease Models, Animal; DNA-Binding Proteins; Fetus; Gene Expression Regulation, Developmental; Gene Knockdown Techniques; Heart Failure; Heart Ventricles; LIM Domain Proteins; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; Paxillin; Phenylephrine; Protein Transport; Rats; Reproducibility of Results; RNA, Small Interfering; Transfection | 2009 |
Tumor suppressor Ras-association domain family 1 isoform A is a novel regulator of cardiac hypertrophy.
Topics: Adenoviridae; Animals; Apoptosis; Cardiomegaly; Cell Line; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Down-Regulation; Heart Failure; Humans; Male; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 3; Myocytes, Cardiac; Phenylephrine; Proto-Oncogene Proteins c-raf; Rats; Rats, Sprague-Dawley; Signal Transduction; Tumor Suppressor Proteins; Vasoconstrictor Agents | 2009 |
Right ventricular failure resulting from pressure overload: role of intra-aortic balloon counterpulsation and vasopressor therapy.
Topics: Animals; Blood Pressure; Combined Modality Therapy; Coronary Circulation; Disease Models, Animal; Heart Failure; Hypertension; Intra-Aortic Balloon Pumping; Phenylephrine; Pulmonary Artery; Sus scrofa; Ultrasonography; Vasoconstrictor Agents; Ventricular Function, Left; Ventricular Pressure | 2010 |
The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis.
Topics: Animals; Cardiomegaly; Cells, Cultured; Connective Tissue Growth Factor; Fibrosis; Heart Failure; Intracellular Signaling Peptides and Proteins; Mice; Mice, Transgenic; Myocardium; Myocytes, Cardiac; Phenylephrine; Pressure; Protein Structure, Tertiary; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2010 |
Thyroid hormone receptor alpha1 downregulation in postischemic heart failure progression: the potential role of tissue hypothyroidism.
Topics: Animals; Animals, Newborn; Disease Progression; Down-Regulation; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Heart Failure; Hypothyroidism; Male; Myocardial Infarction; Myocardial Ischemia; Myocardium; Myocytes, Cardiac; Myosins; Phenylephrine; Protein Isoforms; Rats; Rats, Wistar; Signal Transduction; Thyroid Hormone Receptors alpha; Thyroid Hormones; TOR Serine-Threonine Kinases; Ultrasonography | 2010 |
Use of afterload hemodynamic stress as a practical method for assessing cardiac performance in rats with heart failure.
Topics: Animals; Echocardiography, Stress; Heart Failure; Hemodynamics; Myocardial Infarction; Phenylephrine; Rats; Rats, Wistar; Ventricular Function, Left; Ventricular Remodeling | 2010 |
Urotensin II alters vascular reactivity in animals subjected to volume overload.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetylcholine; Animals; Aorta, Thoracic; Arteriovenous Shunt, Surgical; Cardiac Volume; Heart Failure; Humans; Male; Models, Animal; Nitroprusside; Phenylephrine; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; rho-Associated Kinases; Urotensins; Vasoconstriction; Venae Cavae | 2010 |
Ginseng inhibits cardiomyocyte hypertrophy and heart failure via NHE-1 inhibition and attenuation of calcineurin activation.
Topics: Animals; Calcineurin; Calcineurin Inhibitors; Calcium; Cells, Cultured; Disease Models, Animal; GATA4 Transcription Factor; Heart Failure; Hypertrophy; Myocytes, Cardiac; NFATC Transcription Factors; Panax; Phenylephrine; Plant Extracts; Rats; Rats, Sprague-Dawley; Sodium; Sodium-Hydrogen Exchangers | 2011 |
Clinical and haemodynamic correlates of heart rate turbulence as a non-invasive index of baroreflex sensitivity in chronic heart failure.
Topics: Baroreflex; Cardiac Output; Cardiotonic Agents; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Phenylephrine; Prognosis; Pulmonary Wedge Pressure; Retrospective Studies; Stroke Volume; Ventricular Premature Complexes | 2011 |
Comparison of the prognostic values of invasive and noninvasive assessments of baroreflex sensitivity in heart failure.
Topics: Baroreflex; Blood Pressure; Diagnostic Tests, Routine; Electrocardiography; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Phenylephrine; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Respiratory Mechanics; Retrospective Studies; Sensitivity and Specificity; Vasoconstrictor Agents | 2011 |
Myocardial and systemic iron depletion in heart failure implications for anemia accompanying heart failure.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic beta-Agonists; Aldosterone; Anemia, Iron-Deficiency; Animals; Antigens, CD; Case-Control Studies; Cells, Cultured; Down-Regulation; Female; Heart Failure; Hemoglobins; Humans; Iron; Isoproterenol; Male; Middle Aged; Myocardium; Myocytes, Cardiac; Norepinephrine; Phenylephrine; Rats; Rats, Sprague-Dawley; Receptors, Transferrin; RNA, Messenger; Severity of Illness Index | 2011 |
Terminalia arjuna enhances baroreflex sensitivity and myocardial function in isoproterenol-induced chronic heart failure rats.
Topics: Animals; Antioxidants; Baroreflex; Chronic Disease; Cytokines; Disease Models, Animal; Fatty Acids, Monounsaturated; Female; Fluvastatin; Heart Failure; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Isoproterenol; Male; Nitroprusside; Oxidative Stress; Phenylephrine; Plant Bark; Plant Extracts; Rats; Rats, Wistar; Terminalia; Ventricular Dysfunction, Left | 2012 |
Serine-910 phosphorylation of focal adhesion kinase is critical for sarcomere reorganization in cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Animals, Newborn; Blotting, Western; Cardiomyopathy, Dilated; Cells, Cultured; Dose-Response Relationship, Drug; Endothelin-1; Enzyme Activation; Fluorescence Recovery After Photobleaching; Focal Adhesion Kinase 1; Heart Failure; Humans; Immunoprecipitation; Insulin-Like Growth Factor I; Microscopy, Fluorescence; Mutation; Myocytes, Cardiac; Paxillin; Phenylephrine; Phosphorylation; Protein Kinase C-delta; Rats; Rats, Sprague-Dawley; Recombinant Fusion Proteins; Sarcomeres; Serine; Signal Transduction; src-Family Kinases; Time Factors; Transfection | 2011 |
DHRS7c, a novel cardiomyocyte-expressed gene that is down-regulated by adrenergic stimulation and in heart failure.
Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Biopsy; Cardiomegaly; Disease Models, Animal; Down-Regulation; Endothelin-1; Gene Expression Regulation, Enzymologic; Heart Failure; Humans; Mice; Myocytes, Cardiac; Oxidoreductases; Phenylephrine; Rats; RNA, Messenger; Sarcoplasmic Reticulum; Sympathetic Nervous System | 2012 |
[Anaesthetic management of caesarean section in pregnancy with diabetes and hypertrophic myocardiopathy with restrictive diastolic dysfunction].
Topics: Adult; Anesthesia, Epidural; Anesthesia, Obstetrical; Betamethasone; Cardiomyopathy, Hypertrophic; Cardiovascular Agents; Cesarean Section, Repeat; Diabetes Mellitus, Type 1; Diastole; Female; Heart Failure; Humans; Hypertension, Pulmonary; Hypotension; Infant, Newborn; Intraoperative Complications; Norepinephrine; Oxytocin; Phenylephrine; Pre-Eclampsia; Preanesthetic Medication; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy in Diabetics; Supine Position | 2013 |
Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cardiomegaly; Cyclin-Dependent Kinases; E2F Transcription Factors; Energy Metabolism; Glucose; Heart Failure; Male; Mice; Mice, Inbred C57BL; Myocardium; Oxidation-Reduction; Phenylephrine; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Receptor, Angiotensin, Type 1; Receptors, Adrenergic, alpha; Retinoblastoma Protein; Signal Transduction; Stroke Volume; Time Factors; Ultrasonography; Ventricular Function | 2012 |
Central Rho kinase inhibition restores baroreflex sensitivity and angiotensin II type 1 receptor protein imbalance in conscious rabbits with chronic heart failure.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Baroreflex; Brain Stem; Chronic Disease; Consciousness; Enzyme Inhibitors; Heart; Heart Failure; Heart Rate; Male; Metoprolol; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitroprusside; Phenylephrine; Rabbits; Receptor, Angiotensin, Type 1; rho-Associated Kinases; Sympathetic Nervous System; Vagus Nerve | 2013 |
[Effect of the third generation beta-blockers on ion-regulating renal function in rats with heart failure model].
Topics: Adrenergic beta-Antagonists; Animals; Benzopyrans; Carbazoles; Carvedilol; Disease Models, Animal; Diuresis; Ethanolamines; Heart Failure; Heart Rate; Kidney; Kidney Function Tests; Male; Nebivolol; Phenylephrine; Physical Exertion; Potassium; Propanolamines; Rats; Sodium; Water-Electrolyte Balance | 2012 |
Preservation of the baroreceptor heart rate reflex by chemical sympathectomy in experimental heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Baroreflex; Blood Pressure; Body Weight; Bradycardia; Catecholamines; Coronary Vessels; Disease Models, Animal; Echocardiography; Heart Failure; Heart Rate; Heart Ventricles; Ligation; Myocardial Infarction; Organ Size; Oxidopamine; Phenylephrine; Propranolol; Rats; Rats, Sprague-Dawley; Sympathectomy, Chemical; Ventricular Dysfunction, Left | 2002 |
Increased contribution of alpha 1- vs. beta-adrenoceptor-mediated inotropic response in rats with congestive heart failure.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Cardiotonic Agents; Dose-Response Relationship, Drug; Heart Failure; Isoproterenol; Male; Myocardial Contraction; Norepinephrine; Phenylephrine; Rats; Rats, Wistar; Receptors, Adrenergic; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Vasoconstrictor Agents | 2003 |
Cardiac p300 is involved in myocyte growth with decompensated heart failure.
Topics: Animals; Blotting, Western; Cell Nucleus; COS Cells; DNA; DNA-Binding Proteins; E1A-Associated p300 Protein; Echocardiography; GATA4 Transcription Factor; Heart Failure; Immunohistochemistry; Lysine; Mice; Mice, Transgenic; Myocardium; Nuclear Proteins; Phenylephrine; Phosphorylation; Plasmids; Precipitin Tests; Protein Binding; Protein Processing, Post-Translational; Rats; Signal Transduction; Trans-Activators; Transcription Factors; Transcription, Genetic; Transfection; Zinc Fingers | 2003 |
Correction of hyperaldosteronism and of massive fluid retention of unknown cause by sympathomimetic agents.
Topics: Amphetamine; Edema; Heart Failure; Humans; Hyperaldosteronism; Hypotension; Hypotension, Orthostatic; Phenylephrine; Spironolactone; Sympathomimetics | 1962 |
SURGICAL TREATMENT OF COMPLETE HEART BLOCK. AN ANALYSIS OF 36 CASES.
Topics: Atropine; Chlorothiazide; Diabetes Mellitus; Ephedrine; Geriatrics; Heart Block; Heart Failure; Humans; Hypertension; Hypotension; Isoproterenol; Middle Aged; Morbidity; Mortality; Myocardial Infarction; Pacemaker, Artificial; Phenylephrine; Postoperative Complications; Prognosis; Steroids; Uremia | 1964 |
D. C. CARDIOVERSION CAUSING VENTRICULAR FIBRILLATION.
Topics: Aminophylline; Digoxin; Diuretics; Drug Therapy; Electric Countershock; Electrocardiography; Heart Failure; Humans; Hypotension; Metaraminol; Myocardial Infarction; Organomercury Compounds; Phenylephrine; Quinidine; Tachycardia; Ventricular Fibrillation | 1965 |
The effects of acute afterload change on systolic ventricular function in conscious dogs with normal vs. failing hearts.
Topics: Animals; Blood Pressure; Cardiac Output; Cardiac Pacing, Artificial; Disease Models, Animal; Dogs; Echocardiography; Heart Failure; Linear Models; Nitroprusside; Phenylephrine; Stroke Volume; Vasoconstrictor Agents; Vasodilator Agents; Ventricular Function, Left | 2003 |
Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Cardiomegaly; Celiprolol; Cells, Cultured; Disease Progression; Drug Evaluation, Preclinical; Enzyme Induction; Fibrosis; Gene Expression Regulation; Heart Failure; Hypertrophy; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phenylephrine; Pressure; Rats; RNA, Messenger; Transcription, Genetic; Vasodilator Agents | 2004 |
Differences in tail vascular bed reactivity in rats with and without heart failure following myocardial infarction.
Topics: Animals; Dose-Response Relationship, Drug; Heart Failure; Indomethacin; Male; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phenylephrine; Rats; Rats, Wistar; Tail; Vasoconstriction | 2005 |
Hemodynamic effects of orally administered carvedilol in healthy conscious dogs.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Carvedilol; Dogs; Heart Failure; Heart Rate; Hemodynamics; Isoproterenol; Phenylephrine; Propanolamines; Pulmonary Wedge Pressure; Random Allocation | 2005 |
Carvedilol blockade of alpha1- and beta-adrenoceptor induced inotropic responses in rats with congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Heart Failure; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardial Infarction; Norepinephrine; Papillary Muscles; Phenylephrine; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Vasoconstrictor Agents; Vasodilator Agents | 2005 |
Impact of mitral valve regurgitation evaluated by intraoperative transesophageal echocardiography on long-term outcomes after coronary artery bypass grafting.
Topics: Aged; Aged, 80 and over; Cohort Studies; Coronary Artery Bypass; Coronary Disease; Echocardiography, Transesophageal; Female; Follow-Up Studies; Heart Failure; Humans; Life Tables; Male; Middle Aged; Mitral Valve Insufficiency; Phenylephrine; Postoperative Complications; Proportional Hazards Models; Prospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Ultrasonography, Interventional | 2005 |
Helix-loop-helix protein p8, a transcriptional regulator required for cardiomyocyte hypertrophy and cardiac fibroblast matrix metalloprotease induction.
Topics: Animals; Atrial Natriuretic Factor; Basic Helix-Loop-Helix Transcription Factors; Chromatin; Endothelin-1; Enzyme Induction; Fibroblasts; Gene Expression Regulation, Enzymologic; Heart Failure; HeLa Cells; Humans; Hypertrophy; Matrix Metalloproteinase 13; Matrix Metalloproteinase 9; Myocardium; Myocytes, Cardiac; Neoplasm Proteins; Phenylephrine; Promoter Regions, Genetic; Protein Binding; Proto-Oncogene Proteins c-jun; Rats; RNA, Messenger; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2007 |
Klf2 is an essential regulator of vascular hemodynamic forces in vivo.
Topics: Anemia; Animals; Arteriovenous Malformations; Blood Flow Velocity; Blood Vessels; Cells, Cultured; Embryo, Mammalian; Embryo, Nonmammalian; Endothelium, Vascular; Gene Expression Regulation, Developmental; Genes, Lethal; Heart Failure; Integrases; Kruppel-Like Transcription Factors; Mice; Mice, Knockout; Mice, Transgenic; Microfilament Proteins; Muscle Proteins; Muscle, Smooth; Myocardium; Phenylephrine; Polymerase Chain Reaction; Promoter Regions, Genetic; Receptor, TIE-2; Stress, Mechanical; Transcription, Genetic; Umbilical Veins; Zebrafish | 2006 |
Exercise training enhances baroreflex sensitivity by an angiotensin II-dependent mechanism in chronic heart failure.
Topics: Angiotensin II; Animals; Baroreflex; Chronic Disease; Disease Models, Animal; Down-Regulation; Exercise Therapy; Heart Failure; Hemodynamics; Infusion Pumps, Implantable; Kidney; Male; Medulla Oblongata; Nitroprusside; Phenylephrine; Physical Conditioning, Animal; Rabbits; Receptor, Angiotensin, Type 1; RNA, Messenger; Sympathetic Nervous System; Time Factors; Vasoconstrictor Agents; Vasodilator Agents | 2008 |
Celecoxib modulates hypertrophic signalling and prevents load-induced cardiac dysfunction.
Topics: Animals; Blood Pressure; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic; Celecoxib; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Enzyme Activation; Female; Glycogen Synthase Kinase 3; Heart Failure; Insulin; Mice; Mice, Inbred C57BL; Muscle Proteins; Myocardial Contraction; Myocytes, Cardiac; Natriuretic Peptide, Brain; Phenylephrine; Phosphorylation; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyrazoles; Rabbits; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sulfonamides; Ventricular Dysfunction, Left | 2008 |
Diacylglycerol kinase-epsilon restores cardiac dysfunction under chronic pressure overload: a new specific regulator of Galpha(q) signaling cascade.
Topics: Animals; Aorta, Thoracic; Blotting, Western; Cardiomegaly; Diacylglycerol Kinase; Diglycerides; Disease Models, Animal; Disease Progression; Fetal Proteins; Fibrosis; Gene Expression Regulation; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Failure; Isoenzymes; Ligation; Mice; Mice, Transgenic; Myocardium; Organ Size; Phenylephrine; Protein Kinase C; Rats; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; TRPC Cation Channels; TRPC6 Cation Channel; Ventricular Function, Left | 2008 |
The systolic arterial pressure/end-systolic volume relationship in patients with severe left ventricular dysfunction.
Topics: Adult; Atropine; Blood Pressure; Cardiac Volume; Cardiomyopathy, Dilated; Erythrocytes; Heart Failure; Humans; Middle Aged; Phenylephrine; Radionuclide Imaging; Technetium | 1984 |
Left ventricular mechanics in dilated cardiomyopathy.
Topics: Adolescent; Adult; Blood Pressure; Cardiomyopathy, Dilated; Female; Heart; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Nitroglycerin; Phenylephrine; Stroke Volume | 1984 |
Reversibility of abnormal arterial baroreflex control of heart rate in heart failure.
Topics: Animals; Arteries; Blood Pressure; Dogs; Heart Failure; Heart Rate; Heart Ventricles; Nitroglycerin; Phenylephrine; Pressoreceptors | 1981 |
Paradoxical response to the vasodilators.
Topics: Blood Pressure; Heart Failure; Heart Rate; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Mitral Valve Stenosis; Nitroprusside; Phenylephrine; Pulmonary Artery; Vasodilator Agents | 1982 |
Inhibition of vascular contractions to alpha-adrenoceptor agonists by polymyxin B: impact of heart failure state.
Topics: Animals; Arteries; Dogs; Dose-Response Relationship, Drug; Heart Failure; Male; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Polymyxin B; Saphenous Vein; Vasoconstriction | 1995 |
Nitroprusside infusion improves arterial baroreflex control of heart rate in dogs with chronic congestive heart failure.
Topics: Animals; Baroreflex; Blood Pressure; Cardiac Output; Cardiac Pacing, Artificial; Disease Models, Animal; Dogs; Heart Failure; Heart Rate; Heart Ventricles; Infusions, Intravenous; Nitroprusside; Phenylephrine; Pressoreceptors; Random Allocation; Regression Analysis; Ventricular Function | 1994 |
New directions in the treatment of heart failure: some paradoxical observations.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output, Low; Cardiotonic Agents; Heart Failure; Humans; Metoprolol; Phenylephrine | 1995 |
Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure.
Topics: Adult; Aged; Baroreflex; Blood Pressure; Case-Control Studies; Cold Temperature; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Nitroprusside; Norepinephrine; Phenylephrine; Pressoreceptors; Sympathetic Nervous System; Vasoconstrictor Agents; Vasodilator Agents | 1995 |
Sympathetic modulation of radial artery compliance in congestive heart failure.
Topics: Adult; Blood Pressure; Compliance; Heart Failure; Humans; Hypertension; Papaverine; Phenylephrine; Radial Artery; Sympathetic Nervous System | 1995 |
Endothelium-dependent relaxations in canine coronary arteries are enhanced in early heart failure and persist in recovery.
Topics: Acetylcholine; Adaptation, Physiological; Adrenergic alpha-Agonists; Animals; Azepines; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Endothelium, Vascular; Heart Failure; In Vitro Techniques; Norepinephrine; Phenylephrine; Vasodilation | 1994 |
Forearm vascular responsiveness to alpha 1- and alpha 2-adrenoceptor stimulation in patients with congestive heart failure.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Azepines; Blood Vessels; Female; Forearm; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Phenylephrine; Reference Values | 1994 |
Defective endothelium-mediated control of coronary circulation in conscious dogs after heart failure.
Topics: Acetylcholine; Animals; Blood Pressure; Coronary Circulation; Coronary Vessels; Dogs; Endothelium, Vascular; Heart; Heart Failure; Isoproterenol; Muscle, Smooth, Vascular; Myocardial Contraction; Nitroprusside; Phenylephrine; Receptors, Adrenergic, beta-1; Reference Values; Regional Blood Flow; Vascular Resistance | 1994 |
In vivo assessment of left atrial contractile performance in normal and pathological conditions using a time-varying elastance model.
Topics: Animals; Atrial Function, Left; Calcium Gluconate; Cardiac Pacing, Artificial; Dogs; Female; Heart Failure; Male; Models, Cardiovascular; Myocardial Contraction; Phenylephrine; Regression Analysis; Time Factors | 1994 |
Recovery of attenuated baroreflex sensitivity in conscious dogs after reversal of pacing induced heart failure.
Topics: Animals; Baroreflex; Cardiac Pacing, Artificial; Dogs; Echocardiography; Heart; Heart Failure; Heart Rate; Hemodynamics; Male; Nitroprusside; Norepinephrine; Phenylephrine; Time Factors | 1994 |
Arterial baroreflex regulation of blood pressure in patients with congestive heart failure.
Topics: Baroreflex; Blood Pressure; Carotid Sinus; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Nitroprusside; Norepinephrine; Phenylephrine; Pressoreceptors; Vasoconstriction | 1994 |
Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine.
Topics: Animals; Aortic Valve Stenosis; Culture Techniques; Deoxyepinephrine; Disease Models, Animal; Endothelium, Vascular; Epinephrine; Heart Failure; Male; Methacholine Chloride; Myocardial Infarction; Norepinephrine; Phenylephrine; Rats; Rats, Wistar; Vasodilator Agents | 1993 |
Endocardial function in pacing-induced heart failure in the dog.
Topics: Animals; Cardiac Pacing, Artificial; Dogs; Endocardium; Heart Failure; In Vitro Techniques; Myocardial Contraction; Papillary Muscles; Phenylephrine | 1993 |
Enalaprilat restores sensitivity of baroreflex control of renal and total noradrenaline spillover in heart failure rabbit.
Topics: Animals; Blood Pressure; Doxorubicin; Enalaprilat; Heart Failure; Kidney; Male; Nitroprusside; Norepinephrine; Phenylephrine; Pressoreceptors; Rabbits | 1993 |
Tension-frequency relationships in normal and cardiomyopathic dog and hamster myocardium.
Topics: Animals; Calcium; Cardiomyopathies; Cricetinae; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Heart Failure; Heart Rate; In Vitro Techniques; Mesocricetus; Myocardial Contraction; Papillary Muscles; Phenylephrine; Ryanodine; Species Specificity | 1995 |
Modulation by atrial natriuretic factor of receptor-mediated cyclic AMP-dependent responses in canine pulmonary artery during heart failure.
Topics: Acetylcholine; Animals; Atrial Natriuretic Factor; Bradykinin; Cyclic AMP; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Heart Failure; Muscle Relaxation; Phenylephrine; Pulmonary Artery | 1996 |
Interaction of 5-methyl-urapidil with alpha 1-adrenoceptors in canine blood vessels: impact of pacing-induced heart failure.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Arteries; Cardiac Pacing, Artificial; Dogs; Heart Failure; Hindlimb; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Piperazines; Saphenous Vein; Vasoconstrictor Agents | 1996 |
Comparison between alpha-1 adrenoceptor-mediated and beta adrenoceptor-mediated inotropic components elicited by norepinephrine in failing human ventricular muscle.
Topics: Adrenergic Antagonists; Heart; Heart Failure; Heart Ventricles; Humans; In Vitro Techniques; Myocardial Contraction; Norepinephrine; Phenylephrine; Prazosin; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Timolol | 1997 |
Response of large and small vessels to alpha and beta adrenoceptor stimulation in heart failure: effect of angiotensin converting enzyme inhibition.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Albuterol; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Chronic Disease; Endothelium, Vascular; Femoral Artery; Heart Failure; Hemodynamics; In Vitro Techniques; Lisinopril; Male; Mesenteric Arteries; Muscle Contraction; Muscle Relaxation; Neurotransmitter Agents; Nitroprusside; Phenylephrine; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Renin-Angiotensin System | 1997 |
Autonomic effects on noise recorded during signal-averaged electrocardiography.
Topics: Adrenergic alpha-Agonists; Adrenergic Antagonists; Adrenergic beta-Antagonists; Adult; Artifacts; Atropine; Autonomic Agents; Autonomic Nervous System; Electrocardiography; Epinephrine; Female; Heart Failure; Humans; Isoproterenol; Male; Myocardial Infarction; Nerve Block; Parasympatholytics; Phenylephrine; Reproducibility of Results; Signal Processing, Computer-Assisted; Sympathetic Nervous System; Sympathomimetics | 1997 |
Angiotensin converting enzyme inhibition improves baroreflex-induced noradrenaline spillover responses in rabbits with heart failure.
Topics: Adrenergic alpha-Agonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibiotics, Antineoplastic; Baroreflex; Blood Pressure; Doxorubicin; Enalaprilat; Heart Failure; Heart Rate; Nitroprusside; Norepinephrine; Phenylephrine; Rabbits; Regional Blood Flow; Renal Circulation; Renin-Angiotensin System | 1997 |
Chloroethylclonidine and alpha-adrenoceptor agonist interaction in blood vessels following heart failure.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Arteries; Clonidine; Dogs; Dose-Response Relationship, Drug; Heart Failure; In Vitro Techniques; Male; Methoxamine; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Saphenous Vein | 1997 |
The influence of basal nitric oxide activity on pulmonary vascular resistance in patients with congestive heart failure.
Topics: Adolescent; Adult; Aged; Female; Heart Failure; Humans; Infusions, Intra-Arterial; Laser-Doppler Flowmetry; Male; Middle Aged; Nitric Oxide; omega-N-Methylarginine; Phenylephrine; Pulmonary Circulation; Vascular Resistance | 1998 |
Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Brain; Cardiotonic Agents; Enzyme Inhibitors; Guanabenz; Heart Failure; Heart Rate; Injections, Intraventricular; Losartan; Male; Myocardial Infarction; Nitroprusside; Ouabain; Phenylephrine; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Stress, Physiological; Sympathetic Nervous System | 1999 |
Overexpression of endothelium nitric oxide synthase reverses the diminished vasorelaxation in the hindlimb vasculature in ischemic heart failure in vivo.
Topics: Acetylcholine; Animals; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation; Heart Failure; Hemodynamics; Hindlimb; Myocardial Ischemia; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Perfusion; Phenylephrine; Rats; Rats, Sprague-Dawley; Transfection; Transgenes; Vasoconstrictor Agents; Vasodilation | 1999 |
Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Endothelium, Vascular; Gene Expression Regulation; Guanylate Cyclase; Heart Failure; Myocardial Infarction; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phenylephrine; Rats; Rats, Wistar; Renin; Superoxide Dismutase; Superoxides; Up-Regulation; Vasodilator Agents | 1999 |
Decreased responsiveness of vascular postjunctional alpha1-, alpha2-adrenoceptors and neuropeptide Y1 receptors in rats with heart failure.
Topics: Adrenergic alpha-Agonists; Animals; Atrial Natriuretic Factor; Autonomic Fibers, Preganglionic; Azepines; Blood Pressure; Cardiac Output; Catecholamines; Clonidine; Decerebrate State; Electric Stimulation; Heart Failure; Male; Myocardial Infarction; Phenylephrine; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Neuropeptide Y | 1999 |
Correlation between atrial natriuretic peptide and baroreflex sensitivity in patients with congestive heart failure.
Topics: Aged; Aldosterone; Atrial Natriuretic Factor; Baroreflex; Catecholamines; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Phenylephrine; Stroke Volume | 1999 |
QT interval lengthening in cardiac disease relates more to left ventricular systolic dysfunction than to autonomic function.
Topics: Autonomic Nervous System; Baroreflex; Biomarkers; Echocardiography; Electrocardiography; Epinephrine; Heart Conduction System; Heart Failure; Heart Rate; Humans; Hypertrophy, Left Ventricular; Middle Aged; Myocardial Contraction; Norepinephrine; Phenylephrine; Sympathomimetics; Vagus Nerve; Ventricular Dysfunction, Left | 2000 |
Sympathetic and reflex abnormalities in heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Analysis of Variance; Baroreflex; Blood Pressure; Cardiomyopathy, Dilated; Case-Control Studies; Chromatography, High Pressure Liquid; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Ischemia; Nitroprusside; Norepinephrine; Phenylephrine; Renin; Stroke Volume; Sympathetic Nervous System; Vasodilator Agents | 2001 |
Baroreflex sensitivity and oxidative stress in adriamycin-induced heart failure.
Topics: Analysis of Variance; Animals; Baroreflex; Blood Pressure; Dose-Response Relationship, Drug; Doxorubicin; Glutathione Peroxidase; Heart Failure; Heart Rate; Heart Ventricles; Lipid Peroxidation; Male; Nitroprusside; Oxidative Stress; Phenylephrine; Rats; Rats, Wistar; Vasoconstrictor Agents; Vasodilator Agents | 2001 |
Nitric oxide and cardiac parasympathetic control in human heart failure.
Topics: Adult; Aged; Baroreflex; Blood Pressure; Cardiotonic Agents; Cross-Over Studies; Enzyme Inhibitors; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Parasympathetic Nervous System; Phenylephrine; Single-Blind Method; Vasoconstrictor Agents | 2002 |
Measuring baroreflex sensitivity from the gain function between arterial pressure and heart period.
Topics: Adult; Aged; Baroreflex; Blood Pressure; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Models, Cardiovascular; Myocardial Infarction; Phenylephrine; Signal Processing, Computer-Assisted; Vasoconstrictor Agents | 2002 |
Humoral regulation of vascular resistance after 30 days of pulmonary artery constriction.
Topics: Angiotensin II; Animals; Cardiomegaly; Catecholamines; Dopamine; Epinephrine; Guinea Pigs; Heart Failure; Norepinephrine; Papaverine; Phentolamine; Phenylephrine; Saralasin; Sympathetic Nervous System; Tyrosine 3-Monooxygenase; Vascular Resistance | 1979 |
The effect of local vasodilating agents.
Topics: Acute Disease; Animals; Dogs; Drug Therapy, Combination; Heart Failure; Humans; Myocardial Infarction; Nitroglycerin; Phenylephrine | 1977 |
Aortic input impedance during nitroprusside infusion. A reconsideration of afterload reduction and beneficial action.
Topics: Adult; Aorta; Blood Flow Velocity; Blood Pressure; Cardiac Output; Ferricyanides; Heart Failure; Heart Rate; Humans; Infusions, Parenteral; Middle Aged; Nitroprusside; Phenylephrine; Stroke Volume | 1979 |
Mechanism of failure in acute right ventricular hypertension.
Topics: Acute Disease; Animals; Coronary Circulation; Coronary Disease; Dogs; Heart Failure; Heart Ventricles; Hyperemia; Hypertension; Hypertension, Pulmonary; Phenylephrine | 1979 |
Reduction in myocardial ischemia with nitroglycerin or nitroglycerin plus phenylephrine administered during acute myocardial infarction.
Topics: Acute Disease; Adolescent; Adult; Coronary Circulation; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Electrocardiography; Female; Heart Failure; Hemodynamics; Humans; Ischemia; Male; Middle Aged; Myocardial Infarction; Nitroglycerin; Phenylephrine | 1975 |
Ventricular-load optimization in patients with heart failure.
Topics: Cardiomyopathy, Dilated; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Nitroprusside; Phenylephrine; Ventricular Function, Left | 1992 |
Effects of myocardial alpha 1-adrenergic receptor stimulation and blockade on contractility in humans.
Topics: Adult; Female; Heart Failure; Humans; Infusions, Intra-Arterial; Male; Myocardial Contraction; Phentolamine; Phenylephrine; Receptors, Adrenergic, alpha; Stimulation, Chemical; Ventricular Function, Left | 1991 |
Efficacy of the glyceryl trinitrate transdermal therapeutic system in a dog model of heart failure.
Topics: Administration, Cutaneous; Animals; Cardiac Output; Dextrans; Disease Models, Animal; Dogs; Female; Heart Failure; Hemodynamics; Male; Nitroglycerin; Phenylephrine; Propranolol | 1991 |
Effects of heart failure on baroreflex control of sympathetic neural activity.
Topics: Adult; Aged; Autonomic Fibers, Postganglionic; Blood Pressure; Heart Failure; Heart Rate; Humans; Linear Models; Middle Aged; Muscles; Nitroprusside; Phenylephrine; Pressoreceptors; Sympathetic Nervous System; Vascular Resistance | 1992 |
Modulation of baroreflex and baroreceptor function in experimental heart failure.
Topics: Animals; Blood Pressure; Disease Models, Animal; Dogs; Electrophysiology; Heart Failure; Heart Rate; Nitroglycerin; Ouabain; Phenylephrine; Pressoreceptors; Reflex, Abnormal; Vagotomy | 1991 |
Abnormal baroreflex control of heart rate in decompensated congestive heart failure and reversal after compensation.
Topics: Adaptation, Physiological; Adult; Atropine; Electrocardiography; Female; Heart Failure; Heart Rate; Humans; Isometric Contraction; Male; Middle Aged; Nitrates; Pentanols; Phenylephrine; Pressoreceptors; Valsalva Maneuver | 1991 |
Arterial baroreceptor control of peripheral vascular resistance in experimental heart failure.
Topics: Animals; Blood Pressure; Dogs; Heart Failure; Male; Nitroglycerin; Phenylephrine; Pressoreceptors; Vagotomy; Vascular Resistance | 1990 |
Baroreflex regulation of regional blood flow in congestive heart failure.
Topics: Aged; Aged, 80 and over; Blood Circulation; Female; Forearm; Heart Failure; Hemodynamics; Humans; Lower Body Negative Pressure; Male; Middle Aged; Phenylephrine; Pressoreceptors; Reflex; Regional Blood Flow; Renal Circulation; Splanchnic Circulation; Vasoconstriction | 1990 |
Alpha-adrenoceptors and alpha-adrenoceptor-mediated positive inotropic effects in failing human myocardium.
Topics: Adult; Aged; Calcium; Female; Heart Failure; Humans; In Vitro Techniques; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Papillary Muscles; Phenylephrine; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1988 |
Alpha 1-adrenoceptor activity in arterial smooth muscle following congestive heart failure.
Topics: Acetylcholine; Animals; Dogs; Heart Failure; Hemodynamics; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Potassium Chloride; Receptors, Adrenergic, alpha; Yohimbine | 1989 |
Opiate receptor inhibition improves the blunted baroreflex function in conscious dogs with right-sided congestive heart failure.
Topics: Animals; Blood Pressure; Consciousness; Dogs; Electrocardiography; Enkephalin, Leucine; Heart Failure; Naloxone; Narcotic Antagonists; Oxymorphone; Phenylephrine; Pressoreceptors; Receptors, Opioid; Reflex | 1989 |
Vascular smooth muscle responsiveness to noradrenaline and phenylephrine following experimental heart failure in dogs.
Topics: Animals; Dogs; Foot; Heart Failure; Male; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Saphenous Vein | 1989 |
Arterial baroreflex abnormalities in heart failure. Reversal after orthotopic cardiac transplantation.
Topics: Adult; Aged; Aging; Arteries; Heart; Heart Failure; Heart Transplantation; Humans; Middle Aged; Phenylephrine; Postoperative Period; Pressoreceptors; Reflex | 1989 |
[Correction of arrhythmia in the complex treatment of cardiac insufficiency and heart defects].
Topics: Adolescent; Adult; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Flutter; Cardiac Complexes, Premature; Electric Countershock; Female; Heart Failure; Heart Valve Diseases; Humans; Middle Aged; Morphine; Phenylephrine; Procainamide; Quinidine; Sodium Chloride; Strophanthins; Tachycardia | 1970 |
Alterations in the baroreceptor reflex in conscious dogs with heart failure.
Topics: Animals; Blood Flow Velocity; Cardiomegaly; Carotid Arteries; Dogs; Heart Failure; Heart Rate; Hypertension; Hypertrophy; Kidney; Mesenteric Arteries; Phenylephrine; Pressoreceptors; Pulmonary Valve Stenosis; Reflex; Tricuspid Valve; Vascular Resistance | 1972 |
[Significance of determination of central venous pressure in patients with myocardial infarct complicated by acute circulatory insufficiency].
Topics: Acute Disease; Blood Pressure; Central Venous Pressure; Dextrans; Heart Failure; Humans; Methods; Myocardial Infarction; Norepinephrine; Phenylephrine; Strophanthins | 1969 |
[Prolonged supraventricular ectopic tachycardia in the child. (16 cases)].
Topics: Arrhythmia, Sinus; Child; Child, Preschool; Digoxin; Electrocardiography; Electroconvulsive Therapy; Female; Heart Failure; Hemiplegia; Humans; Infant; Male; Methysergide; Neostigmine; Phenylephrine; Procainamide; Propranolol; Quinidine; Reserpine; Tachycardia | 1969 |